CVRdatabase
Menu

Amplexa Genetics A/S

Public limited companyCVR 29428441Odense CActive

Amplexa Genetics A/S is a public limited company, based in Odense C, active in other technical consultancy, founded in 2006. Equity was negative at the end of 2025 (−DKK 10.3m). The company made a loss in both 2024 and 2025, most recently DKK 1.6m. With 13 employees, the company is about 7 times larger than the industry median.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 4m+18% vs. 2024
Net profit−DKK 1.6m+85.7% vs. 2024
Equity−DKK 10.3m−18.1% vs. 2024
Employees13latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 18% (2024 → 2025), to DKK 4m.
  • The loss got smaller: from DKK 11.1m to DKK 1.6m (2024 → 2025).

Employees

  • 1 fewer employees than a year earlier: 13 (08/2026) against 14 (08/2025).

Management and owners, last 24 months

  • New in management: Magnus Herdalur (chair of the board, 10/04/2026).
  • Stepped down: Johan Jan Albinus Dahl (chair of the board, 10/04/2026).
  • New owners registered: Scient. Invest ApS (31/12/2024) and Sp/f D65 Holding (31/12/2024).
  • No longer registered as owner: Scient. Invest ApS (30/12/2024), Sp/f D65 Holding (30/12/2024) and P/f Norðoya Íløgufelag (31/12/2024).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 25m−DKK 20m−DKK 15m−DKK 10m−DKK 5mDKK 0DKK 5mDKK 10m202020212022202320242025
EquityNet profit
Financial figures for Amplexa Genetics A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit12,42420,2785,4953,2253,3994,009+18%
Operating profit (EBIT)6,45810,437−2,551−4,063−7,963−1,730+78.3%
Profit before tax5,8739,943−3,025−4,046−7,994−1,864+76.7%
Net profit5,87312,328−2,282−3,131−11,108−1,583+85.7%
Total assets12,29118,36312,28414,9763,6472,892−20.7%
Equity−24,537−12,208−14,4912,378−8,730−10,313−18.1%
Liabilities36,82830,57126,77512,59712,37713,206+6.7%
Cash and cash equivalents4,6307,7291,5353,430464590+27.3%
Average number of employees71314151412−14.3%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 5mDKK 10mDKK 15mDKK 20m202020212022202320242025
Gross profitMedian, the industry (440 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 10.3m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 4 years in a row

    Net result has been negative in 2022–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Amplexa Genetics A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202530/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202401/07/2025The companyPDFXBRL
202301/01/2023 – 31/12/202327/05/2024The companyPDFXBRL
202201/01/2022 – 31/12/202224/04/2023The companyPDFXBRL
202101/01/2021 – 31/12/202112/05/2022The companyPDFXBRL
202001/01/2020 – 31/12/202027/05/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101214161809/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

440 companies in the database

Comparison with the other companies in other technical consultancy based on the latest financial year.

Gross profitDKK 4mNo. 129 of 439
Better than 71% of the companies in the industry
Equity−DKK 10.3mNo. 437 of 440
Better than 1% of the companies in the industry
Number of employees13No. 58 of 440
Better than 87% of the companies in the industry

Industry median: gross profit DKK 1.9m, net profit DKK 210k, equity DKK 874k, 2 employees.

DKK 100kDKK 645kDKK 4.2mDKK 26.8mDKK 92.9mHere
Distribution of gross profit for 401 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 17,095of 69,742
Better than 75%
No. 69,599of 69,964
Better than 1%
Same industry and fewer than 20 employees396 companies in the comparison
No. 86of 396
Better than 78%
No. 394of 396
Better than 1%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 11,131of 24,791
Better than 55%
No. 24,761of 24,909
Better than 1%
All companies of type A/S18,025 companies in the comparison
No. 12,766of 17,786
Better than 28%
No. 17,801of 18,024
Better than 1%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Other technical consultancy
Gross profit
  1. Amplexa Genetics A/SDKK 4m
  2. Nordomatic A/SDKK 172.8m
  3. NRGi Rådgivning A/SDKK 113.6m
Net profit
  1. Amplexa Genetics A/S−DKK 1.6m
  2. Nordomatic A/SDKK 37.7m
  3. NRGi Rådgivning A/S−DKK 26.3m
Equity
  1. Amplexa Genetics A/S−DKK 10.3m
  2. Nordomatic A/SDKK 102.5m
  3. NRGi Rådgivning A/SDKK 28.6m
Employees
  1. Amplexa Genetics A/S13
  2. Nordomatic A/S173
  3. NRGi Rådgivning A/S183

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
Amplexa Genetics A/S

Management

4 active registrations

Executive management

Executive management at Amplexa Genetics A/S
NameRoleAppointed
Hans Atli Eli Albinus DahlCEO01/04/2021

Board of directors

Board of directors at Amplexa Genetics A/S
NameRoleAppointed
Eydfinn ReydbergBoard member25/01/2011
Ulf Bech ChristensenBoard member16/03/2023
Magnus HerdalurChair of the board10/04/2026
Founders
P&f Conseco
Former management (13)
Former management at Amplexa Genetics A/S
NameRoleAppointedResigned
Klaus BrusgaardDirector25/03/200631/03/2011
Johan DahlBoard member25/03/200626/09/2008
Marita RasmussenBoard member25/03/200601/12/2010
Andras SplidtBoard member15/12/200801/12/2009
Pál Magni WeiheBoard member01/12/200924/04/2018
Hans Atli Eli Albinus DahlCEO01/04/201101/02/2018
Jørn Kildegaard AndersenChair of the board01/10/201330/09/2015
Nils Christian JensenBoard member01/10/201316/03/2023
Leif MosekildeBoard member01/10/201331/05/2015
Johan Jan Albinus DahlChair of the board02/11/201510/04/2026
Helle HjalgrimCEO01/02/201831/03/2021
Leif AbrahamsenBoard member24/04/201816/03/2023
Charles Steven GlavasBoard member24/04/201816/03/2023

Signing rule: Selskabet tegnes af en direktør sammen med et medlem af bestyrelsen eller af bestyrelsen i forening.

Address and production units

1 active production units

Sverigesgade 24
5000 Odense C

Odense Municipality · Postcode 5000

Production units
Production unitAddressEmployeesP number
AMPLEXA GENETICS A/SSverigesgade 24, 5000 Odense C131012155111

Purpose

Selskabets formål er at arbejde med virksomhed indenfor genetisk screening, dna-undersøgelser samt hermed beslægtet virksomhed

The purpose is quoted from the register in Danish.

Changes year by year

53 registered events
20263 changesaccounts 1 · management 2
  • Annual report for 2025 published
  • Magnus Herdalur appointed chair of the board
  • Johan Jan Albinus Dahl stepped down as chair of the board
20251 changeaccounts 1
  • Annual report for 2024 published
20246 changesownership 5 · accounts 1
  • Sp/f D65 Holding registered as owner (33.33%)
  • SCIENT. INVEST ApS registered as owner (33.33%)
  • P/f Norðoya Íløgufelag is no longer registered as owner
  • Sp/f D65 Holding is no longer registered as owner
  • SCIENT. INVEST ApS is no longer registered as owner
  • Annual report for 2023 published
202312 changesaddress 1 · accounts 1 · capital 1 · ownership 5 · management 4
  • Moved to Sverigesgade 24, 5000 Odense C
  • Annual report for 2022 published
  • Share capital changed from 600,000 DKK to 20,600,000 DKK
  • Sp/f D65 Holding registered as owner (20%)
  • Conseco P/F registered as owner (25%)
  • P/f Norðoya Íløgufelag registered as owner (20%)
  • SCIENT. INVEST ApS registered as owner (20%)
  • Conseco P/F is no longer registered as owner
  • Ulf Bech Christensen appointed board member
  • Charles Steven Glavas stepped down as board member
  • Leif Abrahamsen stepped down as board member
  • Nils Christian Jensen stepped down as board member
20221 changeaccounts 1
  • Annual report for 2021 published
20213 changesaccounts 1 · management 2
  • Annual report for 2020 published
  • Hans Atli Eli Albinus Dahl appointed ceo
  • Helle Hjalgrim stepped down as ceo
20191 changeaddress 1
  • Moved to Sverigesgade 24, 5000 Odense C
20185 changesmanagement 5
  • Charles Steven Glavas appointed board member
  • Leif Abrahamsen appointed board member
  • Pál Magni Weihe stepped down as board member
  • Helle Hjalgrim appointed ceo
  • Hans Atli Eli Albinus Dahl stepped down as ceo
20153 changesmanagement 3
  • Johan Jan Albinus Dahl appointed chair of the board
  • Jørn Kildegaard Andersen stepped down as chair of the board
  • Leif Mosekilde stepped down as board member
20133 changesmanagement 3
  • Leif Mosekilde appointed board member
  • Jørn Kildegaard Andersen appointed chair of the board
  • Nils Christian Jensen appointed board member
20113 changesmanagement 3
  • Hans Atli Eli Albinus Dahl appointed ceo
  • Klaus Brusgaard stepped down as director
  • Eydfinn Reydberg appointed board member
20101 changemanagement 1
  • Marita Rasmussen stepped down as board member
20092 changesmanagement 2
  • Pál Magni Weihe appointed board member
  • Andras Splidt stepped down as board member
20084 changescapital 1 · ownership 1 · management 2
  • Share capital changed from 500,000 DKK to 600,000 DKK
  • Conseco P/F registered as owner (100%)
  • Andras Splidt appointed board member
  • Johan Dahl stepped down as board member
20065 changesindustry 1 · founded 1 · management 3
  • Industry changed to Anden teknisk rådgivning (742090)
  • Registered as AMPLEXA GENETICS A/S
  • Klaus Brusgaard appointed director
  • Marita Rasmussen appointed board member
  • Johan Dahl appointed board member

Related companies

Same industry in Odense

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.

View in CVRReport a correction